Felix S.F. Ram, PhD, Clinical Pharmacologist
Learn more about subscription options.
Register Now for a free account.
Ram FS. Review: Oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD. Ann Intern Med. 2011;155:JC3–2. doi: 10.7326/0003-4819-155-6-201109200-02002
Download citation file:
Published: Ann Intern Med. 2011;155(6):JC3-2.
Chronic Obstructive Airway Disease, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only